Advertisement

Topics

Cystic Fibrosis Enters the Proteomics Scene Company Profile

07:49 EST 16th December 2018 | BioPortfolio

As a continuation to genomic research, proteomics now offers the unique advantage to examine global alterations in the protein expression patterns of CF cells and tissues. The systematic use of proteomics should ultimately result in the finding of new prognostic markers...


News Articles [1070 Associated News Articles listed on BioPortfolio]

Oxford BioMedica Enters Three-way Cystic Fibrosis Partnership

Teams up with UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations

New lung cell type discovered.

Cystic fibrosis is a genetic-based disorder which primarily affects the lungs.  The gene affected by cystic fibrosis is CFTR (cystic fibrosis transmembrane conductance regulator), which controls the...

Triple Combo Regimens May Address Cause of Cystic Fibrosis

FRIDAY, Oct. 19, 2018 -- Triple therapy with VX-659 or VX-445 combined with tezacaftor-ivacaftor shows promise for the treatment of adult patients with cystic fibrosis who have mutations in the cystic...

Boehringer joins UK academics in battle against cystic fibrosis

Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF). T...

Cystic fibrosis impacts directly on intrauterine growth, shows research

New research, published in Thorax, funded by the Cystic Fibrosis Trust has shown that babies with cystic fibrosis are born weighing less than babies without the condition, even allowing that they are ...

Research shows that cystic fibrosis impacts growth in the womb

(University of Liverpool) New research, published in Thorax, funded by the Cystic Fibrosis Trust has shown that babies with cystic fibrosis (CF) are born weighing less than babies without the conditio...

New Gene Therapy Could Treat Cystic Fibrosis With One Dose

A new partnership in the UK will develop a gene therapy for cystic fibrosis that could treat the disease with a single dose. Cystic fibrosis is a genetic disease that causes mucus to build up in a pat...

Greater Manchester MP calls for ‘life-saving’ cystic fibrosis drug to be available on NHS – Mancunian Matters

Mancunian MattersGreater Manchester MP calls for 'life-saving' cystic fibrosis drug to be available on NHSMancunian MattersMP Kate Green says that people living with cystic fibrosis 'deserve better' d...

PubMed Articles [1589 Associated PubMed Articles listed on BioPortfolio]

No easy road to better cystic fibrosis care in Eastern Europe?

Vitamin E status and its determinants in patients with cystic fibrosis.

The risk of vitamin E deficiency is of primary concern in cystic fibrosis patients. However, early diagnosis and routine vitamin E supplementation can lead to its normal or even high levels. In the pr...

SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum.

In healthy lungs, epithelial sodium channel (ENaC) is regulated by short, palate, lung, and nasal clone 1 (SPLUNC1). In cystic fibrosis (CF), ENaC is hyperactivated in part due to a loss of SPLUNC1 fu...

Chloride and sodium ion concentrations in saliva and sweat as a method to diagnose cystic fibrosis.

Cystic fibrosis diagnosis is dependent on the chloride ion concentration in the sweat test (≥60mEq/mL - recognized as the gold standard indicator for cystic fibrosis diagnosis). Moreover, the saliva...

Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry.

The Australian Cystic Fibrosis Data Registry is positioning itself as an exemplar of a rare disease registry for the future. While it continues to inform cystic fibrosis (CF) clinicians of patterns of...

Clinical Trials [1622 Associated Clinical Trials listed on BioPortfolio]

Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

Cystic fibrosis is a genetic disease caused by mutation of the cystic fibrosis transmembrane conductance regulator (CFTR). The purpose of the study is to investigate the effects of miglust...

In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS Technology

In order to further enable physiopathology studies, the aim of this project is to validate an in vitro model of cystic fibrosis created using induced pluripotent stemcell (iPS) differentia...

Exercise-Induced Bronchospasm in Cystic Fibrosis

Exercise is an important clinical feature in cystic fibrosis. Better exercise capacity has been associated with better patient outcomes and quality of life. Exercise-induced bronchospasm...

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

OBJECTIVES: Evaluate the efficacy and safety of lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator gene to nasal epithelium in patients with cystic f...

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

OBJECTIVES: I. Determine the stability of uridine triphosphate (UTP) and examine the metabolism of exogenous nucleotides on airway epithelial surfaces in patients with cystic fibrosis. ...

Companies [299 Associated Companies listed on BioPortfolio]

Cystic Fibrosis Enters the Proteomics Scene

As a continuation to genomic research, proteomics now offers the unique advantage to examine global alterations in the protein expression patterns of CF cells and tissues. The systematic use of proteo...

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available ...

Cystic Fibrosis Foundation, Northern Ohio Chapter

The Northern Ohio Chapter of the Cystic Fibrosis Foundation works to help develop a means to control and cure cystic fibrosis and to improve the lives of those with the dis...

Cystic Fibrosis Trust

•        Cystic fibrosis is chronically misunderstood, kills thousands worldwide and is carried unknowingly in the genes of millions. It's often invisible...

New Lung Associates

New Lung Associates is a pulmonary group of physicians leading the Lung Transplant Program and the Adult Cystic Fibrosis Program at Tampa General Hospital, a 988-bed acute care ho...

More Information about "Cystic Fibrosis Enters the Proteomics Scene" on BioPortfolio

We have published hundreds of Cystic Fibrosis Enters the Proteomics Scene news stories on BioPortfolio along with dozens of Cystic Fibrosis Enters the Proteomics Scene Clinical Trials and PubMed Articles about Cystic Fibrosis Enters the Proteomics Scene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cystic Fibrosis Enters the Proteomics Scene Companies in our database. You can also find out about relevant Cystic Fibrosis Enters the Proteomics Scene Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record